Furthermore, the addition of the rad score to the clinical model could increase the rate of identification of PCa-negative cases by 8.4% in comparison with the clinical model for predicting PCa in cases with PSA in the gray zone. The gene discussed is KLK3; the disease is posterior cortical atrophy.